Shenyang Hongqi Pharmaceutical Co Ltd, based in China, is a pharmaceutical company.
One of their notable products is PRETOMANID, with a corresponding US DMF Number 38642.
Remarkably, this DMF maintains an Active status since its submission on September 28, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 08, 2024, and payment made on December 26, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II